Esophagus Disorder
7
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Efficacy of Carbonated Beverages in the Resolution of Alimentary Esophageal Impaction
Risk Factors for Sub Mucosal Fibrosis During Achalasia Cardia: A Prospective Study
Using Magnetic Field Tracking to Confirm Nasogastric Tube Placement at Point of Care
Progenitor Cells in Human Esophagus
Radiofrequency Ablation for the Treatment of Large Symptomatic Heterotopic Gastric Mucosa
Impact of Antibiotic Prophylaxis in Per-oral Endoscopic Myotomy for Esophageal Motor Disorders
Movantik for Opioid-Related Esophageal Disorders